Obtained mention of PKD in Senate FY2010 Defense appropriations bill for research and clinical funding under Defense Peer Reviewed Medical Research Program (Senate version of H.R. 3326); Obtained report language for PKD forum and clinical treatment centers under FY2010 HHS/NIH/NIDDK appropriations House and Senate bills, H.R. 3293, as passed as part of Consolidated Appropriations Act, H.R. 3288, and obtained funding for PKD education efforts under H.R. 3293 and H.R 3288.
Obtain extension of immunosuppressive drug provisions under federal health programs via hte Senate version of health reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act.
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH)
Bills mentioned
H.R.3326: Department of Defense Appropriations Act, 2010
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Q1 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate